Bellerophon Therapeutics, Inc.
BLPHDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600132
Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Bellerophon Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- 0 vs. Q4 2021
- Shares held
- 1.14M
- −97.0K (−7.9%) vs. Q4 2021
- Total value
- $2.68M
- −$1.14M (−29.9%) vs. Q4 2021
- New holders
- 1
- 3 more added
- Sold out
- 1
- 11 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $6.37K |
| Q3 2023 | 22 | $506.6K |
| Q2 2023 | 23 | $824.9K |
| Q1 2023 | 19 | $27.9M |
| Q4 2022 | 25 | $832.7K |
| Q3 2022 | 19 | $1.18M |
| Q2 2022 | 19 | $1.40M |
| Q1 2022 | 22 | $2.68M |
| Q4 2021 | 22 | $3.82M |
| Q3 2021 | 22 | $4.81M |
| Q2 2021 | 27 | $6.34M |
| Q1 2021 | 39 | $10.9M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Bellerophon Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 360,790 | $852.0K | 0.00% | −9,763−2.6% | Reduced |
| Wells Fargo & Company | 200,052 | $472.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 185,299 | $437.0K | 0.00% | +6,400+3.6% | Added |
| BlackRock Inc. | 120,689 | $285.0K | 0.00% | −981−0.8% | Reduced |
| Telemetry Investments, L.L.C. | 83,584 | $197.0K | 0.32% | −19,197−18.7% | Reduced |
| Geode Capital Management, LLC | 58,341 | $137.0K | 0.00% | −90.0% | Reduced |
| Jane Street Group, LLC | 37,327 | $88.0K | 0.00% | −36,733−49.6% | Reduced |
| Northern Trust Corp | 28,097 | $66.0K | 0.00% | −8,313−22.8% | Reduced |
| State Street Corp | 21,327 | $50.0K | 0.00% | 00.0% | Unchanged |
| Tudor Investment Corp Et Al | 20,000 | $47.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 11,075 | $26.0K | 0.00% | −13,059−54.1% | Reduced |
| UBS Group AG | 2,571 | $6.00K | 0.00% | +351+15.8% | Added |
| Morgan Stanley | 2,195 | $5.00K | 0.00% | −3,292−60.0% | Reduced |
| Tower Research Capital LLC (TRC) | 1,576 | $4.00K | 0.00% | +878+125.8% | Added |
| US Bancorp | 1,221 | $3.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 255 | $1.00K | 0.00% | −2,174−89.5% | Reduced |
| Northwestern Mutual Wealth Management Co | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 153 | $1.00K | 0.00% | −11−6.7% | Reduced |
| JPMorgan Chase & Co | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 43 | $0 | 0.00% | −47−52.2% | Reduced |
| Citigroup Inc | 86 | $0 | 0.00% | +86 | New |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,161−100.0% | Sold out |